nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—PTGS1—Etoposide—urinary bladder cancer	0.0645	0.201	CbGbCtD
Zolpidem—CYP3A4—Thiotepa—urinary bladder cancer	0.0557	0.173	CbGbCtD
Zolpidem—CYP3A5—Etoposide—urinary bladder cancer	0.0387	0.12	CbGbCtD
Zolpidem—CYP1A2—Fluorouracil—urinary bladder cancer	0.0345	0.107	CbGbCtD
Zolpidem—CYP2C9—Fluorouracil—urinary bladder cancer	0.0311	0.0968	CbGbCtD
Zolpidem—CYP1A2—Etoposide—urinary bladder cancer	0.0288	0.0897	CbGbCtD
Zolpidem—CYP2C9—Cisplatin—urinary bladder cancer	0.0264	0.0822	CbGbCtD
Zolpidem—CYP2D6—Doxorubicin—urinary bladder cancer	0.0162	0.0504	CbGbCtD
Zolpidem—CYP3A4—Etoposide—urinary bladder cancer	0.0151	0.047	CbGbCtD
Zolpidem—CYP3A4—Doxorubicin—urinary bladder cancer	0.0103	0.032	CbGbCtD
Zolpidem—Tolmetin—CXCL8—urinary bladder cancer	0.00778	0.483	CrCbGaD
Zolpidem—Tolmetin—MPO—urinary bladder cancer	0.00606	0.376	CrCbGaD
Zolpidem—CYP2C19—urine—urinary bladder cancer	0.00391	0.128	CbGeAlD
Zolpidem—CYP1A2—urine—urinary bladder cancer	0.0032	0.104	CbGeAlD
Zolpidem—CYP2C9—urine—urinary bladder cancer	0.00303	0.0991	CbGeAlD
Zolpidem—CYP3A4—urine—urinary bladder cancer	0.00231	0.0756	CbGeAlD
Zolpidem—CYP2D6—urine—urinary bladder cancer	0.00228	0.0744	CbGeAlD
Zolpidem—Tolmetin—PTGS2—urinary bladder cancer	0.00227	0.141	CrCbGaD
Zolpidem—GABRB3—prostate gland—urinary bladder cancer	0.00162	0.053	CbGeAlD
Zolpidem—CYP3A5—prostate gland—urinary bladder cancer	0.00111	0.0362	CbGeAlD
Zolpidem—PTGS1—prostate gland—urinary bladder cancer	0.000995	0.0325	CbGeAlD
Zolpidem—GABRA2—vagina—urinary bladder cancer	0.000953	0.0311	CbGeAlD
Zolpidem—GABRB3—female reproductive system—urinary bladder cancer	0.000886	0.0289	CbGeAlD
Zolpidem—PTGS1—seminal vesicle—urinary bladder cancer	0.000841	0.0275	CbGeAlD
Zolpidem—CYP1A2—renal system—urinary bladder cancer	0.000782	0.0255	CbGeAlD
Zolpidem—CYP3A5—renal system—urinary bladder cancer	0.000754	0.0246	CbGeAlD
Zolpidem—PTGS1—epithelium—urinary bladder cancer	0.000731	0.0239	CbGeAlD
Zolpidem—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000704	0.023	CbGeAlD
Zolpidem—CYP2C19—vagina—urinary bladder cancer	0.000694	0.0227	CbGeAlD
Zolpidem—PTGS1—renal system—urinary bladder cancer	0.000678	0.0221	CbGeAlD
Zolpidem—GABRA2—lymph node—urinary bladder cancer	0.000617	0.0201	CbGeAlD
Zolpidem—CYP2C9—female reproductive system—urinary bladder cancer	0.000595	0.0194	CbGeAlD
Zolpidem—CYP3A4—renal system—urinary bladder cancer	0.000566	0.0185	CbGeAlD
Zolpidem—CYP2D6—renal system—urinary bladder cancer	0.000557	0.0182	CbGeAlD
Zolpidem—CYP3A5—vagina—urinary bladder cancer	0.000546	0.0178	CbGeAlD
Zolpidem—PTGS1—female reproductive system—urinary bladder cancer	0.000543	0.0177	CbGeAlD
Zolpidem—PTGS1—vagina—urinary bladder cancer	0.000491	0.016	CbGeAlD
Zolpidem—CYP3A4—female reproductive system—urinary bladder cancer	0.000453	0.0148	CbGeAlD
Zolpidem—CYP2D6—female reproductive system—urinary bladder cancer	0.000446	0.0146	CbGeAlD
Zolpidem—PTGS1—lymph node—urinary bladder cancer	0.000318	0.0104	CbGeAlD
Zolpidem—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000254	0.000527	CcSEcCtD
Zolpidem—Urticaria—Etoposide—urinary bladder cancer	0.000253	0.000525	CcSEcCtD
Zolpidem—Stomatitis—Doxorubicin—urinary bladder cancer	0.000253	0.000524	CcSEcCtD
Zolpidem—Rhinitis—Epirubicin—urinary bladder cancer	0.000252	0.000523	CcSEcCtD
Zolpidem—Body temperature increased—Etoposide—urinary bladder cancer	0.000252	0.000522	CcSEcCtD
Zolpidem—Abdominal pain—Etoposide—urinary bladder cancer	0.000252	0.000522	CcSEcCtD
Zolpidem—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000252	0.000522	CcSEcCtD
Zolpidem—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000252	0.000522	CcSEcCtD
Zolpidem—Eye disorder—Methotrexate—urinary bladder cancer	0.000251	0.000521	CcSEcCtD
Zolpidem—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000251	0.000521	CcSEcCtD
Zolpidem—Tinnitus—Methotrexate—urinary bladder cancer	0.000251	0.00052	CcSEcCtD
Zolpidem—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00025	0.000519	CcSEcCtD
Zolpidem—Asthenia—Cisplatin—urinary bladder cancer	0.00025	0.000518	CcSEcCtD
Zolpidem—Pharyngitis—Epirubicin—urinary bladder cancer	0.00025	0.000518	CcSEcCtD
Zolpidem—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00025	0.000517	CcSEcCtD
Zolpidem—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000248	0.000515	CcSEcCtD
Zolpidem—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000247	0.000512	CcSEcCtD
Zolpidem—Urethral disorder—Epirubicin—urinary bladder cancer	0.000247	0.000511	CcSEcCtD
Zolpidem—Epistaxis—Doxorubicin—urinary bladder cancer	0.000245	0.000507	CcSEcCtD
Zolpidem—Sinusitis—Doxorubicin—urinary bladder cancer	0.000243	0.000504	CcSEcCtD
Zolpidem—Dizziness—Fluorouracil—urinary bladder cancer	0.000243	0.000503	CcSEcCtD
Zolpidem—Visual impairment—Epirubicin—urinary bladder cancer	0.000242	0.000503	CcSEcCtD
Zolpidem—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000242	0.000502	CcSEcCtD
Zolpidem—Chills—Methotrexate—urinary bladder cancer	0.000241	0.0005	CcSEcCtD
Zolpidem—Diarrhoea—Cisplatin—urinary bladder cancer	0.000238	0.000494	CcSEcCtD
Zolpidem—Vomiting—Gemcitabine—urinary bladder cancer	0.000237	0.000492	CcSEcCtD
Zolpidem—Mental disorder—Methotrexate—urinary bladder cancer	0.000236	0.000488	CcSEcCtD
Zolpidem—Rash—Gemcitabine—urinary bladder cancer	0.000235	0.000488	CcSEcCtD
Zolpidem—Dermatitis—Gemcitabine—urinary bladder cancer	0.000235	0.000488	CcSEcCtD
Zolpidem—Eye disorder—Epirubicin—urinary bladder cancer	0.000235	0.000487	CcSEcCtD
Zolpidem—Hypersensitivity—Etoposide—urinary bladder cancer	0.000235	0.000487	CcSEcCtD
Zolpidem—Tinnitus—Epirubicin—urinary bladder cancer	0.000235	0.000486	CcSEcCtD
Zolpidem—Erythema—Methotrexate—urinary bladder cancer	0.000234	0.000485	CcSEcCtD
Zolpidem—Malnutrition—Methotrexate—urinary bladder cancer	0.000234	0.000485	CcSEcCtD
Zolpidem—Headache—Gemcitabine—urinary bladder cancer	0.000234	0.000485	CcSEcCtD
Zolpidem—Flushing—Epirubicin—urinary bladder cancer	0.000234	0.000484	CcSEcCtD
Zolpidem—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000234	0.000484	CcSEcCtD
Zolpidem—Vomiting—Fluorouracil—urinary bladder cancer	0.000233	0.000484	CcSEcCtD
Zolpidem—Rhinitis—Doxorubicin—urinary bladder cancer	0.000233	0.000484	CcSEcCtD
Zolpidem—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000232	0.00048	CcSEcCtD
Zolpidem—Rash—Fluorouracil—urinary bladder cancer	0.000232	0.00048	CcSEcCtD
Zolpidem—Dermatitis—Fluorouracil—urinary bladder cancer	0.000231	0.000479	CcSEcCtD
Zolpidem—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000231	0.000479	CcSEcCtD
Zolpidem—Headache—Fluorouracil—urinary bladder cancer	0.00023	0.000477	CcSEcCtD
Zolpidem—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.00023	0.000476	CcSEcCtD
Zolpidem—Dysgeusia—Methotrexate—urinary bladder cancer	0.000229	0.000475	CcSEcCtD
Zolpidem—Asthenia—Etoposide—urinary bladder cancer	0.000229	0.000474	CcSEcCtD
Zolpidem—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000229	0.000474	CcSEcCtD
Zolpidem—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000228	0.000473	CcSEcCtD
Zolpidem—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000227	0.00047	CcSEcCtD
Zolpidem—Back pain—Methotrexate—urinary bladder cancer	0.000226	0.000469	CcSEcCtD
Zolpidem—Chills—Epirubicin—urinary bladder cancer	0.000226	0.000468	CcSEcCtD
Zolpidem—Pruritus—Etoposide—urinary bladder cancer	0.000226	0.000468	CcSEcCtD
Zolpidem—Arrhythmia—Epirubicin—urinary bladder cancer	0.000225	0.000466	CcSEcCtD
Zolpidem—Visual impairment—Doxorubicin—urinary bladder cancer	0.000224	0.000465	CcSEcCtD
Zolpidem—Nausea—Gemcitabine—urinary bladder cancer	0.000222	0.00046	CcSEcCtD
Zolpidem—Vomiting—Cisplatin—urinary bladder cancer	0.000221	0.000459	CcSEcCtD
Zolpidem—Vision blurred—Methotrexate—urinary bladder cancer	0.000221	0.000457	CcSEcCtD
Zolpidem—Mental disorder—Epirubicin—urinary bladder cancer	0.00022	0.000457	CcSEcCtD
Zolpidem—Rash—Cisplatin—urinary bladder cancer	0.000219	0.000455	CcSEcCtD
Zolpidem—Dermatitis—Cisplatin—urinary bladder cancer	0.000219	0.000454	CcSEcCtD
Zolpidem—Erythema—Epirubicin—urinary bladder cancer	0.000219	0.000454	CcSEcCtD
Zolpidem—Malnutrition—Epirubicin—urinary bladder cancer	0.000219	0.000454	CcSEcCtD
Zolpidem—Diarrhoea—Etoposide—urinary bladder cancer	0.000218	0.000452	CcSEcCtD
Zolpidem—Nausea—Fluorouracil—urinary bladder cancer	0.000218	0.000452	CcSEcCtD
Zolpidem—Eye disorder—Doxorubicin—urinary bladder cancer	0.000218	0.000451	CcSEcCtD
Zolpidem—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000217	0.00045	CcSEcCtD
Zolpidem—Tinnitus—Doxorubicin—urinary bladder cancer	0.000217	0.00045	CcSEcCtD
Zolpidem—Anaemia—Methotrexate—urinary bladder cancer	0.000216	0.000448	CcSEcCtD
Zolpidem—Flushing—Doxorubicin—urinary bladder cancer	0.000216	0.000448	CcSEcCtD
Zolpidem—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000216	0.000448	CcSEcCtD
Zolpidem—Flatulence—Epirubicin—urinary bladder cancer	0.000216	0.000447	CcSEcCtD
Zolpidem—Tension—Epirubicin—urinary bladder cancer	0.000215	0.000445	CcSEcCtD
Zolpidem—Dysgeusia—Epirubicin—urinary bladder cancer	0.000214	0.000445	CcSEcCtD
Zolpidem—Nervousness—Epirubicin—urinary bladder cancer	0.000213	0.000441	CcSEcCtD
Zolpidem—Back pain—Epirubicin—urinary bladder cancer	0.000212	0.000439	CcSEcCtD
Zolpidem—Malaise—Methotrexate—urinary bladder cancer	0.000211	0.000437	CcSEcCtD
Zolpidem—Dizziness—Etoposide—urinary bladder cancer	0.000211	0.000437	CcSEcCtD
Zolpidem—Muscle spasms—Epirubicin—urinary bladder cancer	0.000211	0.000436	CcSEcCtD
Zolpidem—Vertigo—Methotrexate—urinary bladder cancer	0.00021	0.000436	CcSEcCtD
Zolpidem—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00021	0.000435	CcSEcCtD
Zolpidem—Leukopenia—Methotrexate—urinary bladder cancer	0.000209	0.000434	CcSEcCtD
Zolpidem—Chills—Doxorubicin—urinary bladder cancer	0.000209	0.000433	CcSEcCtD
Zolpidem—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000208	0.000431	CcSEcCtD
Zolpidem—Nausea—Cisplatin—urinary bladder cancer	0.000207	0.000429	CcSEcCtD
Zolpidem—Vision blurred—Epirubicin—urinary bladder cancer	0.000206	0.000428	CcSEcCtD
Zolpidem—Cough—Methotrexate—urinary bladder cancer	0.000204	0.000423	CcSEcCtD
Zolpidem—Mental disorder—Doxorubicin—urinary bladder cancer	0.000204	0.000423	CcSEcCtD
Zolpidem—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000203	0.000421	CcSEcCtD
Zolpidem—Vomiting—Etoposide—urinary bladder cancer	0.000203	0.00042	CcSEcCtD
Zolpidem—Erythema—Doxorubicin—urinary bladder cancer	0.000203	0.00042	CcSEcCtD
Zolpidem—Malnutrition—Doxorubicin—urinary bladder cancer	0.000203	0.00042	CcSEcCtD
Zolpidem—Anaemia—Epirubicin—urinary bladder cancer	0.000202	0.00042	CcSEcCtD
Zolpidem—Agitation—Epirubicin—urinary bladder cancer	0.000201	0.000417	CcSEcCtD
Zolpidem—Rash—Etoposide—urinary bladder cancer	0.000201	0.000417	CcSEcCtD
Zolpidem—Dermatitis—Etoposide—urinary bladder cancer	0.000201	0.000416	CcSEcCtD
Zolpidem—Headache—Etoposide—urinary bladder cancer	0.0002	0.000414	CcSEcCtD
Zolpidem—Flatulence—Doxorubicin—urinary bladder cancer	0.0002	0.000414	CcSEcCtD
Zolpidem—Myalgia—Methotrexate—urinary bladder cancer	0.000199	0.000413	CcSEcCtD
Zolpidem—Chest pain—Methotrexate—urinary bladder cancer	0.000199	0.000413	CcSEcCtD
Zolpidem—Arthralgia—Methotrexate—urinary bladder cancer	0.000199	0.000413	CcSEcCtD
Zolpidem—Tension—Doxorubicin—urinary bladder cancer	0.000199	0.000412	CcSEcCtD
Zolpidem—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000198	0.000411	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000198	0.00041	CcSEcCtD
Zolpidem—Malaise—Epirubicin—urinary bladder cancer	0.000198	0.000409	CcSEcCtD
Zolpidem—Discomfort—Methotrexate—urinary bladder cancer	0.000197	0.000408	CcSEcCtD
Zolpidem—Nervousness—Doxorubicin—urinary bladder cancer	0.000197	0.000408	CcSEcCtD
Zolpidem—Vertigo—Epirubicin—urinary bladder cancer	0.000197	0.000408	CcSEcCtD
Zolpidem—Syncope—Epirubicin—urinary bladder cancer	0.000196	0.000407	CcSEcCtD
Zolpidem—Leukopenia—Epirubicin—urinary bladder cancer	0.000196	0.000406	CcSEcCtD
Zolpidem—Back pain—Doxorubicin—urinary bladder cancer	0.000196	0.000406	CcSEcCtD
Zolpidem—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000195	0.000404	CcSEcCtD
Zolpidem—Palpitations—Epirubicin—urinary bladder cancer	0.000194	0.000401	CcSEcCtD
Zolpidem—Confusional state—Methotrexate—urinary bladder cancer	0.000193	0.000399	CcSEcCtD
Zolpidem—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000193	0.000399	CcSEcCtD
Zolpidem—Cough—Epirubicin—urinary bladder cancer	0.000191	0.000396	CcSEcCtD
Zolpidem—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000191	0.000396	CcSEcCtD
Zolpidem—Vision blurred—Doxorubicin—urinary bladder cancer	0.000191	0.000396	CcSEcCtD
Zolpidem—Infection—Methotrexate—urinary bladder cancer	0.00019	0.000393	CcSEcCtD
Zolpidem—Nausea—Etoposide—urinary bladder cancer	0.000189	0.000393	CcSEcCtD
Zolpidem—Hypertension—Epirubicin—urinary bladder cancer	0.000189	0.000392	CcSEcCtD
Zolpidem—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000188	0.00039	CcSEcCtD
Zolpidem—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000187	0.000388	CcSEcCtD
Zolpidem—Anaemia—Doxorubicin—urinary bladder cancer	0.000187	0.000388	CcSEcCtD
Zolpidem—Arthralgia—Epirubicin—urinary bladder cancer	0.000186	0.000386	CcSEcCtD
Zolpidem—Myalgia—Epirubicin—urinary bladder cancer	0.000186	0.000386	CcSEcCtD
Zolpidem—Chest pain—Epirubicin—urinary bladder cancer	0.000186	0.000386	CcSEcCtD
Zolpidem—Agitation—Doxorubicin—urinary bladder cancer	0.000186	0.000386	CcSEcCtD
Zolpidem—Anxiety—Epirubicin—urinary bladder cancer	0.000186	0.000385	CcSEcCtD
Zolpidem—Skin disorder—Methotrexate—urinary bladder cancer	0.000186	0.000385	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000185	0.000384	CcSEcCtD
Zolpidem—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000185	0.000383	CcSEcCtD
Zolpidem—Discomfort—Epirubicin—urinary bladder cancer	0.000184	0.000382	CcSEcCtD
Zolpidem—Malaise—Doxorubicin—urinary bladder cancer	0.000183	0.000379	CcSEcCtD
Zolpidem—Dry mouth—Epirubicin—urinary bladder cancer	0.000182	0.000378	CcSEcCtD
Zolpidem—Vertigo—Doxorubicin—urinary bladder cancer	0.000182	0.000377	CcSEcCtD
Zolpidem—Anorexia—Methotrexate—urinary bladder cancer	0.000182	0.000377	CcSEcCtD
Zolpidem—Syncope—Doxorubicin—urinary bladder cancer	0.000182	0.000377	CcSEcCtD
Zolpidem—Leukopenia—Doxorubicin—urinary bladder cancer	0.000181	0.000376	CcSEcCtD
Zolpidem—Confusional state—Epirubicin—urinary bladder cancer	0.00018	0.000374	CcSEcCtD
Zolpidem—Palpitations—Doxorubicin—urinary bladder cancer	0.000179	0.000371	CcSEcCtD
Zolpidem—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000179	0.00037	CcSEcCtD
Zolpidem—Oedema—Epirubicin—urinary bladder cancer	0.000179	0.00037	CcSEcCtD
Zolpidem—Hypotension—Methotrexate—urinary bladder cancer	0.000178	0.00037	CcSEcCtD
Zolpidem—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000178	0.000369	CcSEcCtD
Zolpidem—Infection—Epirubicin—urinary bladder cancer	0.000178	0.000368	CcSEcCtD
Zolpidem—Cough—Doxorubicin—urinary bladder cancer	0.000177	0.000367	CcSEcCtD
Zolpidem—Shock—Epirubicin—urinary bladder cancer	0.000176	0.000364	CcSEcCtD
Zolpidem—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000175	0.000363	CcSEcCtD
Zolpidem—Hypertension—Doxorubicin—urinary bladder cancer	0.000175	0.000363	CcSEcCtD
Zolpidem—Tachycardia—Epirubicin—urinary bladder cancer	0.000174	0.000362	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000174	0.000361	CcSEcCtD
Zolpidem—Skin disorder—Epirubicin—urinary bladder cancer	0.000174	0.00036	CcSEcCtD
Zolpidem—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000173	0.000358	CcSEcCtD
Zolpidem—Insomnia—Methotrexate—urinary bladder cancer	0.000173	0.000358	CcSEcCtD
Zolpidem—Chest pain—Doxorubicin—urinary bladder cancer	0.000173	0.000358	CcSEcCtD
Zolpidem—Myalgia—Doxorubicin—urinary bladder cancer	0.000173	0.000358	CcSEcCtD
Zolpidem—Arthralgia—Doxorubicin—urinary bladder cancer	0.000173	0.000358	CcSEcCtD
Zolpidem—Anxiety—Doxorubicin—urinary bladder cancer	0.000172	0.000356	CcSEcCtD
Zolpidem—Paraesthesia—Methotrexate—urinary bladder cancer	0.000172	0.000355	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000171	0.000355	CcSEcCtD
Zolpidem—Discomfort—Doxorubicin—urinary bladder cancer	0.00017	0.000353	CcSEcCtD
Zolpidem—Anorexia—Epirubicin—urinary bladder cancer	0.00017	0.000353	CcSEcCtD
Zolpidem—Dyspnoea—Methotrexate—urinary bladder cancer	0.00017	0.000353	CcSEcCtD
Zolpidem—Somnolence—Methotrexate—urinary bladder cancer	0.00017	0.000352	CcSEcCtD
Zolpidem—Dry mouth—Doxorubicin—urinary bladder cancer	0.000169	0.00035	CcSEcCtD
Zolpidem—Dyspepsia—Methotrexate—urinary bladder cancer	0.000168	0.000348	CcSEcCtD
Zolpidem—Hypotension—Epirubicin—urinary bladder cancer	0.000167	0.000346	CcSEcCtD
Zolpidem—Confusional state—Doxorubicin—urinary bladder cancer	0.000167	0.000346	CcSEcCtD
Zolpidem—Decreased appetite—Methotrexate—urinary bladder cancer	0.000166	0.000344	CcSEcCtD
Zolpidem—Oedema—Doxorubicin—urinary bladder cancer	0.000165	0.000343	CcSEcCtD
Zolpidem—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000165	0.000343	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000165	0.000342	CcSEcCtD
Zolpidem—Fatigue—Methotrexate—urinary bladder cancer	0.000165	0.000341	CcSEcCtD
Zolpidem—Infection—Doxorubicin—urinary bladder cancer	0.000164	0.000341	CcSEcCtD
Zolpidem—Pain—Methotrexate—urinary bladder cancer	0.000163	0.000339	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000163	0.000338	CcSEcCtD
Zolpidem—Shock—Doxorubicin—urinary bladder cancer	0.000163	0.000337	CcSEcCtD
Zolpidem—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000162	0.000336	CcSEcCtD
Zolpidem—Insomnia—Epirubicin—urinary bladder cancer	0.000162	0.000335	CcSEcCtD
Zolpidem—Tachycardia—Doxorubicin—urinary bladder cancer	0.000161	0.000335	CcSEcCtD
Zolpidem—Skin disorder—Doxorubicin—urinary bladder cancer	0.000161	0.000333	CcSEcCtD
Zolpidem—Paraesthesia—Epirubicin—urinary bladder cancer	0.000161	0.000333	CcSEcCtD
Zolpidem—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00016	0.000331	CcSEcCtD
Zolpidem—Dyspnoea—Epirubicin—urinary bladder cancer	0.000159	0.00033	CcSEcCtD
Zolpidem—Somnolence—Epirubicin—urinary bladder cancer	0.000159	0.000329	CcSEcCtD
Zolpidem—Anorexia—Doxorubicin—urinary bladder cancer	0.000158	0.000327	CcSEcCtD
Zolpidem—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000157	0.000326	CcSEcCtD
Zolpidem—Dyspepsia—Epirubicin—urinary bladder cancer	0.000157	0.000326	CcSEcCtD
Zolpidem—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000156	0.000324	CcSEcCtD
Zolpidem—Decreased appetite—Epirubicin—urinary bladder cancer	0.000155	0.000322	CcSEcCtD
Zolpidem—Hypotension—Doxorubicin—urinary bladder cancer	0.000155	0.00032	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000154	0.00032	CcSEcCtD
Zolpidem—Fatigue—Epirubicin—urinary bladder cancer	0.000154	0.000319	CcSEcCtD
Zolpidem—Pain—Epirubicin—urinary bladder cancer	0.000153	0.000317	CcSEcCtD
Zolpidem—Constipation—Epirubicin—urinary bladder cancer	0.000153	0.000317	CcSEcCtD
Zolpidem—Urticaria—Methotrexate—urinary bladder cancer	0.000152	0.000314	CcSEcCtD
Zolpidem—Abdominal pain—Methotrexate—urinary bladder cancer	0.000151	0.000313	CcSEcCtD
Zolpidem—Body temperature increased—Methotrexate—urinary bladder cancer	0.000151	0.000313	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000151	0.000312	CcSEcCtD
Zolpidem—Insomnia—Doxorubicin—urinary bladder cancer	0.00015	0.00031	CcSEcCtD
Zolpidem—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000149	0.000308	CcSEcCtD
Zolpidem—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000147	0.000306	CcSEcCtD
Zolpidem—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000147	0.000305	CcSEcCtD
Zolpidem—Somnolence—Doxorubicin—urinary bladder cancer	0.000147	0.000305	CcSEcCtD
Zolpidem—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000146	0.000303	CcSEcCtD
Zolpidem—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000146	0.000302	CcSEcCtD
Zolpidem—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000144	0.000298	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000143	0.000296	CcSEcCtD
Zolpidem—Fatigue—Doxorubicin—urinary bladder cancer	0.000143	0.000296	CcSEcCtD
Zolpidem—Urticaria—Epirubicin—urinary bladder cancer	0.000142	0.000294	CcSEcCtD
Zolpidem—Pain—Doxorubicin—urinary bladder cancer	0.000141	0.000293	CcSEcCtD
Zolpidem—Constipation—Doxorubicin—urinary bladder cancer	0.000141	0.000293	CcSEcCtD
Zolpidem—Abdominal pain—Epirubicin—urinary bladder cancer	0.000141	0.000293	CcSEcCtD
Zolpidem—Body temperature increased—Epirubicin—urinary bladder cancer	0.000141	0.000293	CcSEcCtD
Zolpidem—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000141	0.000292	CcSEcCtD
Zolpidem—Asthenia—Methotrexate—urinary bladder cancer	0.000137	0.000284	CcSEcCtD
Zolpidem—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000136	0.000282	CcSEcCtD
Zolpidem—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000135	0.00028	CcSEcCtD
Zolpidem—Pruritus—Methotrexate—urinary bladder cancer	0.000135	0.00028	CcSEcCtD
Zolpidem—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000132	0.000273	CcSEcCtD
Zolpidem—Urticaria—Doxorubicin—urinary bladder cancer	0.000131	0.000272	CcSEcCtD
Zolpidem—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000131	0.000271	CcSEcCtD
Zolpidem—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000131	0.000271	CcSEcCtD
Zolpidem—Diarrhoea—Methotrexate—urinary bladder cancer	0.000131	0.000271	CcSEcCtD
Zolpidem—Asthenia—Epirubicin—urinary bladder cancer	0.000128	0.000266	CcSEcCtD
Zolpidem—Pruritus—Epirubicin—urinary bladder cancer	0.000126	0.000262	CcSEcCtD
Zolpidem—Dizziness—Methotrexate—urinary bladder cancer	0.000126	0.000262	CcSEcCtD
Zolpidem—Diarrhoea—Epirubicin—urinary bladder cancer	0.000122	0.000253	CcSEcCtD
Zolpidem—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000122	0.000253	CcSEcCtD
Zolpidem—Vomiting—Methotrexate—urinary bladder cancer	0.000121	0.000252	CcSEcCtD
Zolpidem—Rash—Methotrexate—urinary bladder cancer	0.00012	0.00025	CcSEcCtD
Zolpidem—Dermatitis—Methotrexate—urinary bladder cancer	0.00012	0.000249	CcSEcCtD
Zolpidem—Headache—Methotrexate—urinary bladder cancer	0.00012	0.000248	CcSEcCtD
Zolpidem—Asthenia—Doxorubicin—urinary bladder cancer	0.000119	0.000246	CcSEcCtD
Zolpidem—Dizziness—Epirubicin—urinary bladder cancer	0.000118	0.000245	CcSEcCtD
Zolpidem—Pruritus—Doxorubicin—urinary bladder cancer	0.000117	0.000243	CcSEcCtD
Zolpidem—Vomiting—Epirubicin—urinary bladder cancer	0.000114	0.000236	CcSEcCtD
Zolpidem—Nausea—Methotrexate—urinary bladder cancer	0.000113	0.000235	CcSEcCtD
Zolpidem—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000113	0.000235	CcSEcCtD
Zolpidem—Rash—Epirubicin—urinary bladder cancer	0.000113	0.000234	CcSEcCtD
Zolpidem—Dermatitis—Epirubicin—urinary bladder cancer	0.000113	0.000233	CcSEcCtD
Zolpidem—Headache—Epirubicin—urinary bladder cancer	0.000112	0.000232	CcSEcCtD
Zolpidem—Dizziness—Doxorubicin—urinary bladder cancer	0.000109	0.000227	CcSEcCtD
Zolpidem—Nausea—Epirubicin—urinary bladder cancer	0.000106	0.00022	CcSEcCtD
Zolpidem—Vomiting—Doxorubicin—urinary bladder cancer	0.000105	0.000218	CcSEcCtD
Zolpidem—Rash—Doxorubicin—urinary bladder cancer	0.000104	0.000216	CcSEcCtD
Zolpidem—Dermatitis—Doxorubicin—urinary bladder cancer	0.000104	0.000216	CcSEcCtD
Zolpidem—Headache—Doxorubicin—urinary bladder cancer	0.000104	0.000215	CcSEcCtD
Zolpidem—Nausea—Doxorubicin—urinary bladder cancer	9.82e-05	0.000204	CcSEcCtD
Zolpidem—CYP3A5—Metabolism—NAT1—urinary bladder cancer	8.84e-05	0.000591	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	8.66e-05	0.000579	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	8.42e-05	0.000564	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.31e-05	0.000556	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	8.08e-05	0.000541	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	7.96e-05	0.000533	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	7.76e-05	0.000519	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.49e-05	0.000501	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—TYMP—urinary bladder cancer	7.41e-05	0.000496	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	7.28e-05	0.000487	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	7.21e-05	0.000482	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.2e-05	0.000482	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—TYMP—urinary bladder cancer	7.18e-05	0.00048	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.14e-05	0.000478	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	7.07e-05	0.000473	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.02e-05	0.000469	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.98e-05	0.000467	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.97e-05	0.000466	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.9e-05	0.000461	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	6.87e-05	0.00046	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.85e-05	0.000458	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NAT1—urinary bladder cancer	6.83e-05	0.000457	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	6.83e-05	0.000457	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.72e-05	0.00045	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—NAT2—urinary bladder cancer	6.7e-05	0.000448	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	6.7e-05	0.000448	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	6.63e-05	0.000443	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.62e-05	0.000443	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	6.57e-05	0.00044	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	6.5e-05	0.000435	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—NAT2—urinary bladder cancer	6.49e-05	0.000434	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.41e-05	0.000429	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.31e-05	0.000422	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	6.28e-05	0.00042	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NAT1—urinary bladder cancer	6.28e-05	0.00042	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	6.25e-05	0.000418	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	6.23e-05	0.000417	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NAT1—urinary bladder cancer	6.23e-05	0.000417	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.2e-05	0.000415	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.16e-05	0.000412	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.13e-05	0.00041	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.05e-05	0.000405	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.98e-05	0.0004	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—RRM2—urinary bladder cancer	5.78e-05	0.000387	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	5.75e-05	0.000385	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—HRAS—urinary bladder cancer	5.74e-05	0.000384	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	5.7e-05	0.000381	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	5.63e-05	0.000376	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	5.62e-05	0.000376	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—RRM2—urinary bladder cancer	5.6e-05	0.000375	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—HRAS—urinary bladder cancer	5.47e-05	0.000366	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—HRAS—urinary bladder cancer	5.38e-05	0.00036	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	5.36e-05	0.000358	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—ENO2—urinary bladder cancer	5.36e-05	0.000358	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—TYMP—urinary bladder cancer	5.35e-05	0.000358	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—HRAS—urinary bladder cancer	5.34e-05	0.000357	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	5.32e-05	0.000356	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NAT1—urinary bladder cancer	5.32e-05	0.000356	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	5.31e-05	0.000355	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.29e-05	0.000354	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—HRAS—urinary bladder cancer	5.25e-05	0.000351	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.24e-05	0.00035	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	5.19e-05	0.000347	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—ENO2—urinary bladder cancer	5.19e-05	0.000347	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—HPGDS—urinary bladder cancer	5.19e-05	0.000347	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	5.18e-05	0.000346	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	5.17e-05	0.000346	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.16e-05	0.000345	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	5.13e-05	0.000343	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GSTT1—urinary bladder cancer	5.03e-05	0.000337	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.96e-05	0.000332	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	4.89e-05	0.000327	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	4.87e-05	0.000326	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	4.84e-05	0.000324	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—NAT2—urinary bladder cancer	4.84e-05	0.000324	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	4.76e-05	0.000319	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	4.72e-05	0.000316	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—HRAS—urinary bladder cancer	4.58e-05	0.000307	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	4.38e-05	0.000293	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.33e-05	0.00029	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—NQO1—urinary bladder cancer	4.32e-05	0.000289	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—NQO1—urinary bladder cancer	4.18e-05	0.00028	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—RRM2—urinary bladder cancer	4.18e-05	0.00028	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.15e-05	0.000278	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	4.14e-05	0.000277	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—TYMP—urinary bladder cancer	4.14e-05	0.000277	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.11e-05	0.000275	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.11e-05	0.000275	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.06e-05	0.000272	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	4.03e-05	0.00027	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.98e-05	0.000266	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	3.87e-05	0.000259	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—ENO2—urinary bladder cancer	3.87e-05	0.000259	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—TYMP—urinary bladder cancer	3.81e-05	0.000255	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.79e-05	0.000253	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—TYMP—urinary bladder cancer	3.77e-05	0.000253	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.76e-05	0.000251	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	3.75e-05	0.000251	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NAT2—urinary bladder cancer	3.74e-05	0.00025	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.63e-05	0.000243	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	3.6e-05	0.000241	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.54e-05	0.000237	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GSTP1—urinary bladder cancer	3.49e-05	0.000233	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.44e-05	0.00023	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NAT2—urinary bladder cancer	3.41e-05	0.000228	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.38e-05	0.000226	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.38e-05	0.000226	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—TYMS—urinary bladder cancer	3.35e-05	0.000224	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	3.31e-05	0.000221	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	3.31e-05	0.000221	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—TYMS—urinary bladder cancer	3.24e-05	0.000217	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.23e-05	0.000216	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—RRM2—urinary bladder cancer	3.23e-05	0.000216	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—TYMP—urinary bladder cancer	3.23e-05	0.000216	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—NCOR1—urinary bladder cancer	3.21e-05	0.000215	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GSTM1—urinary bladder cancer	3.21e-05	0.000215	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.2e-05	0.000214	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GPX1—urinary bladder cancer	3.17e-05	0.000212	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—NQO1—urinary bladder cancer	3.12e-05	0.000209	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.11e-05	0.000208	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	3.11e-05	0.000208	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.1e-05	0.000207	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GPX1—urinary bladder cancer	3.07e-05	0.000205	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—ERCC2—urinary bladder cancer	3.02e-05	0.000202	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.99e-05	0.0002	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.99e-05	0.0002	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.98e-05	0.000199	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.97e-05	0.000199	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.95e-05	0.000197	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	2.92e-05	0.000196	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.92e-05	0.000195	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.9e-05	0.000194	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.86e-05	0.000191	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—MTHFR—urinary bladder cancer	2.83e-05	0.00019	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.75e-05	0.000184	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.75e-05	0.000184	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.73e-05	0.000183	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.73e-05	0.000183	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.71e-05	0.000181	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.67e-05	0.000179	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.65e-05	0.000177	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.61e-05	0.000174	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	2.6e-05	0.000174	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.52e-05	0.000168	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.49e-05	0.000167	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—TYMS—urinary bladder cancer	2.42e-05	0.000162	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.41e-05	0.000161	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	2.39e-05	0.00016	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	2.39e-05	0.00016	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PPARG—urinary bladder cancer	2.37e-05	0.000159	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.34e-05	0.000157	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.33e-05	0.000156	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.33e-05	0.000156	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.32e-05	0.000155	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PPARG—urinary bladder cancer	2.3e-05	0.000154	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GPX1—urinary bladder cancer	2.29e-05	0.000153	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	2.28e-05	0.000152	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.26e-05	0.000151	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.25e-05	0.000151	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	2.25e-05	0.00015	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.23e-05	0.000149	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.22e-05	0.000148	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CREBBP—urinary bladder cancer	2.21e-05	0.000148	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.2e-05	0.000147	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.13e-05	0.000143	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	2.11e-05	0.000141	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.04e-05	0.000137	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.01e-05	0.000135	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.95e-05	0.00013	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.94e-05	0.00013	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.88e-05	0.000126	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.87e-05	0.000125	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.87e-05	0.000125	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.86e-05	0.000125	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.85e-05	0.000124	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.85e-05	0.000124	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.85e-05	0.000124	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.83e-05	0.000123	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.82e-05	0.000122	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.81e-05	0.000121	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.8e-05	0.00012	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.8e-05	0.00012	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.77e-05	0.000119	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.77e-05	0.000118	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.75e-05	0.000117	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.74e-05	0.000116	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.72e-05	0.000115	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.71e-05	0.000115	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.71e-05	0.000114	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.7e-05	0.000114	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.7e-05	0.000114	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.69e-05	0.000113	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.69e-05	0.000113	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.65e-05	0.00011	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.63e-05	0.000109	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.63e-05	0.000109	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PTEN—urinary bladder cancer	1.63e-05	0.000109	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.61e-05	0.000108	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.6e-05	0.000107	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.59e-05	0.000106	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.59e-05	0.000106	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.58e-05	0.000105	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.57e-05	0.000105	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—EP300—urinary bladder cancer	1.55e-05	0.000104	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.52e-05	0.000101	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—EP300—urinary bladder cancer	1.5e-05	0.000101	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.5e-05	0.000101	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.49e-05	9.97e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.46e-05	9.75e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.45e-05	9.7e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.44e-05	9.64e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.44e-05	9.64e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.38e-05	9.23e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.35e-05	9.06e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.35e-05	9.02e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.33e-05	8.86e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.27e-05	8.52e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.27e-05	8.52e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.22e-05	8.15e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.21e-05	8.09e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.21e-05	8.08e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.18e-05	7.87e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.17e-05	7.83e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.16e-05	7.76e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.12e-05	7.52e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.12e-05	7.5e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.11e-05	7.44e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.11e-05	7.44e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.06e-05	7.12e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.05e-05	6.99e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.04e-05	6.97e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.03e-05	6.91e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	9.92e-06	6.64e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	9.83e-06	6.57e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	9.59e-06	6.41e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	9.5e-06	6.36e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PTEN—urinary bladder cancer	9.09e-06	6.08e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—EP300—urinary bladder cancer	8.67e-06	5.8e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PTEN—urinary bladder cancer	8.36e-06	5.59e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PTEN—urinary bladder cancer	8.29e-06	5.54e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	8.12e-06	5.43e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—EP300—urinary bladder cancer	7.97e-06	5.33e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.97e-06	5.33e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—EP300—urinary bladder cancer	7.9e-06	5.29e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	7.65e-06	5.12e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PTEN—urinary bladder cancer	7.08e-06	4.74e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—EP300—urinary bladder cancer	6.75e-06	4.52e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.27e-06	4.19e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.47e-06	3.66e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.21e-06	3.49e-05	CbGpPWpGaD
